ENSCO, Inc. Announces New Contract to Assess Bio Threats

ENSCO recently won the first phase of an innovative new contract with the Department of Homeland Security (DHS) Science and Technology (S&T) Directorate’s SenseNet program to research and develop a system using low-cost environmental monitoring sensors to address the Bio threat. This program supports DHS’s mission, which includes preventing, detecting, responding to, and recovering from intentional or accidental introduction of aerosolized biological and chemical agents.

Under this first phase contract, ENSCO will design and model a smart system that integrates data from densely deployed, low-cost, environmental monitoring sensors with best of breed confirmation technology provided by its partner PositiveID. ENSCO will add unique event processing, false alarm reduction, and source location capabilities into an open and flexible architecture to illustrate how this system meets DHS’s ambitious, high performance and low cost challenge.

“We are especially proud to win this contract with the DHS S&T Directorate because it is a new customer for ENSCO and one we hope to establish a long-term relationship with,” said Dr. Michael Glass, Vice President, National Security Solutions Division of ENSCO. “Further, it is the result of cross-division collaboration and combining capabilities from across the company to meet the unique needs of this important customer.”

About ENSCO, Inc.

ENSCO, Inc., and its wholly owned subsidiaries represent a $90 million technology enterprise, headquartered in the Washington, D.C., area. For more than 45 years, the ENSCO group of companies has been providing ingenious engineering, science and advanced technology solutions that guarantee mission success, safety and security to governments and private industries around the globe. ENSCO operates in the defense, transportation, aerospace and intelligence sectors. Field offices and subsidiaries, representatives and partnerships are located throughout the United States and around the world. Learn more

About PositiveID Corporation

PositiveID Corporation is an emerging growth company and developer of biological detection systems for America’s homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. For more information on PositiveID, please visit www.PositiveIDCorp.com.